Medical innovation

Iran-born anti-regime Nasdaq biotech investor says he is trying to cure ‘two cancers’ - interview

Iran-born US biotech CEO Amir Heshmatpour says his Nasdaq-listed brain cancer company will begin treating patients in Israel within weeks, as he also voices support for ending Iran’s clerical rule.

Amir Heshmatpour.
ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.

Israeli firm receives FDA approval to begin clinical trial of chronic corneal edema treatment

Medex launches in Australia with first-ever events in Sydney

MedEx Launches in Australia with First-Ever Events in Sydney and Melbourne

Cancer ilustration image.

New and improved ‘killer’ cells show promise in staving off cancer spread - study


Israel's Assuta permitted to expand IVF operations following scandals

The public hospitals’ IVF units had said that it was difficult for the to meet the demand of women for fertility treatments without the participation of private hospitals. 

 Pregnant woman suffers from depression (Illustrative)

This breakthrough may help doctors tell if you'll get schizophrenia later in life

The team hopes that the discovery, and those that follow, could help create targeted therapies going forward.

 The brain (illustrative).

New Israeli/American research supports benefit of remote medical services to reduce hospital visits

Telemedicine reduces the need for patients to rush to crowded emergency rooms by 20% without harming quality of care.

Device allows vitals to be taken remotely from home

Israeli doctors, scientist promote cooperation with Brazil in visit

They stressed the need for unity among academia, industry, and healthcare in both countries, as well as for the benefit of global medicine.

 Israeli delegation, members of the MCTI and the Israeli ambassador to Brazil, Daniel Zonshine